Home > Boards > US Listed > Biotechs > Amarin Corp. PLC ADS (AMRN)

Nice ideas, but I see some immediate problems:

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
sts66 Member Profile
 
Followed By 59
Posts 13,134
Boards Moderated 0
Alias Born 04/26/10
160x600 placeholder
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 6/1/2020 4:15:58 PM
Amarin Plans to Increase VASCEPA® (icosapent ethyl) Promotion and Education GlobeNewswire Inc. - 6/1/2020 7:00:10 AM
Amarin Supports Trial to Investigate the Effects of VASCEPA® (icosapent ethyl) in the Treatment of COVID-19 GlobeNewswire Inc. - 5/21/2020 4:05:10 PM
VASCEPA® (icosapent ethyl) Shows Significant Reduction in Coronary Revascularization, Including Coronary Stenting and Cardia... GlobeNewswire Inc. - 5/14/2020 2:50:10 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/8/2020 5:19:58 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 4/30/2020 6:39:17 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/30/2020 6:32:26 AM
Amarin Reports First Quarter 2020 Financial Results and Provides Update on Operations GlobeNewswire Inc. - 4/30/2020 5:00:10 AM
Amended Annual Report (10-k/a) Edgar (US Regulatory) - 4/29/2020 4:12:49 PM
Amarin to Report First Quarter 2020 Results and Host Conference Call on April 30, 2020 GlobeNewswire Inc. - 4/28/2020 7:00:10 AM
Cannabis? CBD? That's Old News, A New Sector Bull Run Has Begun InvestorsHub NewsWire - 4/16/2020 8:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/13/2020 4:37:32 PM
Amarin to Host Conference Call on April 13, 2020 to Provide Preliminary First Quarter 2020 Results and Operational Update GlobeNewswire Inc. - 4/8/2020 4:05:10 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 3/31/2020 9:23:01 AM
Amarin Highlights VASCEPA® (Icosapent Ethyl)-Related Data Presented at American College of Cardiology’s Annual Scientific ... GlobeNewswire Inc. - 3/31/2020 7:00:10 AM
Amarin Comments on Ruling in VASCEPA® ANDA Litigation GlobeNewswire Inc. - 3/30/2020 6:25:32 PM
Eicosapentaenoic Acid (EPA) Levels From VASCEPA® (Icosapent Ethyl) in REDUCE-IT® Strongly Correlated with Cardiovascular Ou... GlobeNewswire Inc. - 3/30/2020 11:45:10 AM
Pharmaceutical Firms Curtailing In-Person Sales Calls to Doctors Dow Jones News - 3/16/2020 2:29:00 PM
Eight Data Presentations Relevant to VASCEPA® (Icosapent Ethyl) Capsules and Persistent Cardiovascular Risk to be Presented ... GlobeNewswire Inc. - 3/16/2020 8:00:10 AM
Amarin Takes Proactive Steps to Support Public Health Priorities GlobeNewswire Inc. - 3/15/2020 1:56:22 PM
Automatic Shelf Registration Statement of Securities of Well-known Seasoned Issuers (s-3asr) Edgar (US Regulatory) - 2/26/2020 5:24:33 PM
ALYI Trending VERY BULLISH at $0.004 with 1000% ROI Potential InvestorsHub NewsWire - 2/26/2020 8:58:36 AM
Annual Report (10-k) Edgar (US Regulatory) - 2/25/2020 4:11:55 PM
sts66   Saturday, 05/23/20 03:49:17 PM
Re: zmanindc post# 275518
Post # of 277701 
Nice ideas, but I see some immediate problems:

1. The price control issue - companies would have incentive to start with a very high price so the limitation of linking price increases to the CPI is bypassed.

a) if they do that, they risk not getting enough patients on the drug because cost is too high - V was priced low to encourage uptake while we waited for R-IT results.

b) companies would not be able to raise prices to increase profits in order to develop new indications and drugs.

c) The CPI is a garbage number and everyone knows it does not represent actual inflation.

2. The "Consumer Pricing and Protection Provision" is DOA - imposing coverage requirements and price controls on commercial insurers is unconstitutional - the HHS has limited ability to require coverage of certain drugs for Medicare plans because it's a government insurance plan funded by taxpayers, but in general they cannot force Part D providers to cover specific drugs. Heck, this applies to (1) too - drug price controls - Congress and BP will never allow it, especially linking prices to government subsidized drug coverage in the EU.



The Thought Police: To censor and protect. Craig Bruce
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist